These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 121346)

  • 1. Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone.
    Verebey K; Mulé SJ
    NIDA Res Monogr; 1979; 27():296-301. PubMed ID: 121346
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of naltrexone in man.
    Wall ME; Brine DR; Perez-Reyes M
    NIDA Res Monogr; 1981; 28():105-31. PubMed ID: 6790999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative determination of naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN) in human plasma, red blood cells, saliva and urine by gas liquid chromatography.
    Verebey K
    NIDA Res Monogr; 1981; 28():36-51. PubMed ID: 6791012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacology of naltrexone: pharmacology and pharmacodynamics.
    Verebey K
    NIDA Res Monogr; 1981; 28():147-58. PubMed ID: 6791001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.
    Malspeis L; Bathala MS; Ludden TM; Bhat HB; Frank SG; Sokoloski TD; Morrison BE; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):43-65. PubMed ID: 810832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
    McCaul ME; Wand GS; Rohde C; Lee SM
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry.
    Toennes SW; Kauert GF; Grüsser SM; Jäkel W; Partecke G
    J Pharm Biomed Anal; 2004 Apr; 35(1):169-76. PubMed ID: 15030891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone disposition in man after subcutaneous administration.
    Wall ME; Perez-Reyes M; Brine DR; Cook CE
    Drug Metab Dispos; 1984; 12(6):677-82. PubMed ID: 6150815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and identification of a new metabolite of naltrexone in human blood and urine.
    Verebely K; Chedekel MA; Mule SJ; Rosenthal D
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):67-84. PubMed ID: 1188187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seminal excretion, plasma elimination, tissue distribution and metabolism of naltrexone in the rabbit.
    Taylor SM; Rodgers RM; Lynn RK; Gerber N
    J Pharmacol Exp Ther; 1980 May; 213(2):289-99. PubMed ID: 7365688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of radioactivity following administration of [15,16-3H]naltrexone to rats and guinea pigs.
    Ludden TM; Bathala MS; Malspeis L; Drum MA; Reuning RH
    Drug Metab Dispos; 1978; 6(3):321-8. PubMed ID: 26554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC; Fujimoto JM; Wang RI
    Drug Metab Dispos; 1980; 8(5):295-9. PubMed ID: 6107224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.
    Malspeis L; Ludden TM; Bathala MS; Morrison BE; Feller DR; Reuning RH
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):393-406. PubMed ID: 822483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon-13 nuclear magnetic resonance identification of 2-hydroxy-3-O-methyl-6beta-naltrexol as a minor naltrexone metabolite.
    Brine GA; Brine DR; Welch CD; Bondeson VC; Carroll FI
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):455-64. PubMed ID: 734225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
    Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson RC
    Addict Biol; 2004 Mar; 9(1):67-72. PubMed ID: 15203441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography.
    Verebey K; De Pace A; Jukofsky D; Volavka JV; Mulé SJ
    J Anal Toxicol; 1980; 4(1):33-7. PubMed ID: 6927049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.
    Verebey K; Volavka J; Mulé SJ; Resnick RB
    Clin Pharmacol Ther; 1976 Sep; 20(3):315-28. PubMed ID: 954353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF; Page-Sharp M; Kristensen JH; O'Neil G; Ilett KF
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.